COVID-19 Information Read the Latest
Children's Hospital is part of the UPMC family.
Our Sites
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #6 Nationally by U.S. News & World Report.
This study seeks to determine whether bilateral orthotopic lung transplantation (BOLT) followed by partially matched hematopoietic stem cell transplantation (HSCT) from the same donor is safe and effective for patients with primary immunodeficiency (PID) and end-stage lung disease. Although HSCT is a curative, life-saving treatment for patients with PID, these patients are often ineligible for HSCT because of pulmonary complications brought on by chronic or recurrent infections resulting from the PID. Researchers believe that by restoring pulmonary function with a lung transplant, patients may be able to proceed to HSCT to cure the underlying immunodeficiency and, quite possibly, provide freedom from all immunosuppressive drugs.
Subject to certain exclusion criteria, the study is accepting participants of both genders between the ages of 5 and 45 who have evidence of an underlying primary immunodeficiency for which HSCT is clinically indicated and who concurrently have end-stage lung disease. Males: 5 to 45 years old Females: 5 to 45 years old
Participants in this study will have both a double lung transplant and a stem cell transplant. The lung transplant will occur at least 6 weeks before the stem cell transplant, allowing sufficient time for recovery from the lung transplant. Due to the severity of participants’ lung disease, the process includes a reduced intensity regimen of the chemotherapy, radiation and drugs that are needed suppress the immune system so the body does not reject transplanted stem cells. Visits: Requires hospitalization and surgery Duration: Initially after discharge, patients will be seen at the bone marrow transplant clinic several times a week, then at 6 months, 1 and 2 years.
Study Description from the National Institutes of Health
Paul Szabolcs, MD
For information about the study or enrollment, please contact: Shawna McIntyre, Clinical Research Supervisor 412-692-5552
*Original research initiated by investigators at UPMC Children’s Hospital of Pittsburgh.
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh One Children’s Hospital Way 4401 Penn Ave. Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.